Neuronetics shares are trading higher after the company announced its NeuroStar Advanced Therapy for Mental Health received FDA clearance for the treatment of anxious depression.
Neuronetics shares are trading higher after the company announced its NeuroStar Advanced Therapy for Mental Health received FDA clearance for the treatment of anxious depression.
Neuronetics的股价上涨，此前该公司宣布其NeuroStar高级心理健康疗法获得FDA批准，用于治疗焦虑性抑郁症。
Neuronetics shares are trading higher after the company announced its NeuroStar Advanced Therapy for Mental Health received FDA clearance for the treatment of anxious depression.
Neuronetics的股价上涨，此前该公司宣布其NeuroStar高级心理健康疗法获得FDA批准，用于治疗焦虑性抑郁症。